KR20130066630A - 자가면역 질환의 치료 - Google Patents

자가면역 질환의 치료 Download PDF

Info

Publication number
KR20130066630A
KR20130066630A KR1020127031868A KR20127031868A KR20130066630A KR 20130066630 A KR20130066630 A KR 20130066630A KR 1020127031868 A KR1020127031868 A KR 1020127031868A KR 20127031868 A KR20127031868 A KR 20127031868A KR 20130066630 A KR20130066630 A KR 20130066630A
Authority
KR
South Korea
Prior art keywords
alkyl
formula
alkoxy
halogen
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020127031868A
Other languages
English (en)
Korean (ko)
Inventor
피터 게르겔리
에릭 발스트로엠
Original Assignee
노파르티스 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42199281&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20130066630(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 노파르티스 아게 filed Critical 노파르티스 아게
Publication of KR20130066630A publication Critical patent/KR20130066630A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/24—Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/28—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/30—Sulfides having the sulfur atom of at least one thio group bound to two carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1020127031868A 2010-05-06 2011-05-05 자가면역 질환의 치료 Withdrawn KR20130066630A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10162079 2010-05-06
EP10162079.7 2010-05-06
PCT/EP2011/057203 WO2011138393A1 (en) 2010-05-06 2011-05-05 Treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
KR20130066630A true KR20130066630A (ko) 2013-06-20

Family

ID=42199281

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127031868A Withdrawn KR20130066630A (ko) 2010-05-06 2011-05-05 자가면역 질환의 치료

Country Status (24)

Country Link
US (1) US20130172297A1 (https=)
EP (1) EP2566470A1 (https=)
JP (1) JP2013530937A (https=)
KR (1) KR20130066630A (https=)
CN (1) CN102869353A (https=)
AU (1) AU2011249784B2 (https=)
BR (1) BR112012028190A2 (https=)
CA (1) CA2795394A1 (https=)
CL (1) CL2012003091A1 (https=)
CR (1) CR20120566A (https=)
CU (1) CU20120154A7 (https=)
EA (1) EA201201514A1 (https=)
EC (1) ECSP12012312A (https=)
IL (1) IL222690A0 (https=)
MA (1) MA34285B1 (https=)
MX (1) MX2012012926A (https=)
NZ (1) NZ603999A (https=)
PE (1) PE20130612A1 (https=)
PH (1) PH12012502418A1 (https=)
SG (1) SG185746A1 (https=)
TN (1) TN2012000509A1 (https=)
TW (1) TW201201814A (https=)
WO (1) WO2011138393A1 (https=)
ZA (1) ZA201207710B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI519539B (zh) * 2010-12-21 2016-02-01 Kyorin Seiyaku Kk Diphenyl sulfide derivatives and pharmaceuticals as an active ingredient thereof
US9289494B2 (en) * 2013-11-20 2016-03-22 RestorTears, LLC Method of treating ocular disorders with compounds found in Harderian gland secretions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2461212C (en) 2001-09-27 2010-08-17 Kyorin Pharmaceutical Co., Ltd. Diaryl sulfide derivatives, salts thereof and immunosuppressive agents using the same
DE60235900D1 (de) * 2001-09-27 2010-05-20 Kyorin Seiyaku Kk Osuppressivum
JP4571497B2 (ja) * 2002-09-19 2010-10-27 杏林製薬株式会社 アミノアルコール誘導体とその付加塩及び免疫抑制剤
BRPI0407658A (pt) * 2003-02-18 2006-02-21 Kyorin Seiyaku Kk derivados de ácido aminofosfÈnico, seus sais e hidratos que atuam como moduladores de receptor de s1p e agente farmacêutico
EP1628957B1 (en) * 2003-05-26 2010-09-29 Takeda Pharmaceutical Company Limited Sulfopyrroles
ATE449069T1 (de) 2003-08-28 2009-12-15 Novartis Pharma Gmbh Aminopropanolderivate
CA2553704C (en) * 2004-02-11 2011-04-19 Basilea Pharmaceutica Ag Substituted benzimidazoles and their use for inducing apoptosis
WO2006041015A1 (ja) * 2004-10-12 2006-04-20 Kyorin Pharmaceutical Co., Ltd. アミノアルコール誘導体とその付加塩及び免疫抑制剤
GB0504544D0 (en) * 2005-03-04 2005-04-13 Novartis Ag Organic compounds
ES2529724T3 (es) * 2005-09-09 2015-02-25 Novartis Ag Tratamiento de enfermedades autoinmunes

Also Published As

Publication number Publication date
WO2011138393A1 (en) 2011-11-10
EP2566470A1 (en) 2013-03-13
ECSP12012312A (es) 2012-12-28
CA2795394A1 (en) 2011-11-10
CU20120154A7 (es) 2013-03-27
TW201201814A (en) 2012-01-16
NZ603999A (en) 2014-06-27
CR20120566A (es) 2013-01-09
JP2013530937A (ja) 2013-08-01
IL222690A0 (en) 2012-12-31
ZA201207710B (en) 2013-06-26
MA34285B1 (fr) 2013-06-01
PE20130612A1 (es) 2013-06-06
EA201201514A1 (ru) 2013-05-30
MX2012012926A (es) 2012-12-17
AU2011249784A1 (en) 2012-12-20
PH12012502418A1 (en) 2018-03-21
SG185746A1 (en) 2013-01-30
US20130172297A1 (en) 2013-07-04
AU2011249784B2 (en) 2014-03-06
CL2012003091A1 (es) 2013-03-22
TN2012000509A1 (en) 2014-04-01
CN102869353A (zh) 2013-01-09
BR112012028190A2 (pt) 2016-08-02

Similar Documents

Publication Publication Date Title
US8008286B2 (en) Method for treatment of neuropathic pain
EP3795566B1 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
KR20110018897A (ko) 수용성 아세트아미노펜 유사체
CN105061376A (zh) 色甘酸衍生物以及成像和治疗的相关方法
AU2014340182A1 (en) Cromolyn derivatives and related methods of imaging and treatment
US20210024477A1 (en) Cystine diamide analogs for the prevention of cystine stone formation in cystinuria
KR20130066630A (ko) 자가면역 질환의 치료
WO2022164901A1 (en) Enhanced anti-proliferative and antitumor immune effects of mitochondria-targeted hydroxyurea
CN111320662A (zh) 一类n-苄基取代的二脒那秦衍生物及其药物用途
US20240174608A1 (en) Compounds for brain imaging
JP7819298B2 (ja) Ｅｐ４拮抗剤化合物及びその塩、結晶多形並びに使用
US9745275B2 (en) Pain-related compound and medical composition
US20250129083A1 (en) Imidazotetrazine compounds and treatment of tmz-resistant cancers
JP2019142815A (ja) 心不全改善剤
EP3858357A1 (en) Use of azole compounds to stimulate the immune system and as inhibitors for s-pla2gib
CN117597122A (zh) 拟甲状腺素药的脂肪酸酰胺水解酶(faah)可裂解前药以及与外周限制性faah抑制剂的组合
JP2025533120A (ja) イミダゾリジニルバニリン酸エーテル誘導体の線維化を伴う疾患の治療における使用
RU2421219C1 (ru) Ингибиторы протеинкиназы с
WO2022119864A1 (en) Compounds for the treatment of sars
US20150087682A1 (en) Method for Treating Scleroderma
JPH0449230A (ja) トロンボキサンＡ↓ｚ拮抗剤
HK1165214B (en) Bicyclic aryl sphingosine 1-phosphate analogs
CN102659617A (zh) L-酪氨酸类衍生物及其药物组合物与应用

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20121205

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid